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Introduction
The meat of intact male pigs may exhibit odours, known
as boar taint. The compounds responsible for boar taint
include skatole (3-methylindole), a product of tryp-
tophan breakdown in the gut and testicular 16-andros-
tene steroids, mainly androstenone (5α-androst-16-en-3-
one), and these compounds are accumulated in fat tissue.
Active immunization against androstenone has been
tried, but the effects on fat androstenone level and boar
odour intensity were insufficient [1]. Other methods
which have been tried in several species are pharmacolog-
ical manipulations of gonadotropin releasing hormone
(GnRH) activity, such as GnRH antagonists or large doses
of agonists to block the activity of GnRH and thereby
"switch-off" the reproductive endocrine systems. More
successful method of inhibiting sexual development in
young boars and boar taint is immunization against
GnRH. In most experimental studies using GnRH vaccines
during the eighties and early nineties several injections
were required and/or severe local reactions at the site of
injection were obtained due to the adjuvans (e.g. Falvo et
al. [2]; Hagen et al. [3]; Bonneau et al. [4]. In this paper
GnRH vaccine developed during late nineties and early
twenties is presented and discussed.
Hormonal background – mechanism of a GnRH 
vaccine
Androstenone is produced by the Leydig cells of the testis.
The production of androstenone and other testicular ster-
oids is controlled by the neuroendocrine system, particu-
larly by LH. LH-secretion is mainly regulated by GnRH
produced by the hypothalamus. LH binds to the receptors
on the surface of the Leydig cells, resulting in the induc-
tion of steroidogenic enzymes and increased levels of tes-
ticular steroids. The biosynthesis of androstenone is low
in young male pigs, but increases at puberty in parallel
with other testicular steroids.
Measurements of GnRH and LH (rat, ram) have shown
that GnRH and LH are secreted in a pulsatile manner, with
a high degree of concordance between GnRH and LH
pulses. The testes exert negative feedback actions on the
hypothalamo-pituitary unit. The predominant site at
which testicular steroids act to regulate the secretion of LH
seems to be within the central nervous system, not at the
level of the pituitary gland [5]. How testosterone and/or
its primary metabolites act within the brain to suppress
the synthesis and/or secretion of GnRH remains essen-
tially unknown.
GnRH, a small peptide (decapeptide) is released from the
hypothalamus into the hypophysial portal blood. It is
produced in cell bodies of hypothalamic neurons and is
transported by axonal flow to the terminal buttons, which
synapse on the vessels of the primary capillary plexus
within the median eminence [6-8]. Exitation of the GnRH
neurons causes release of stored peptide from the secre-
tory granules into the extracellular space, with eventual
diffusion into the capillary blood. This blood then travels
via the hypophysial portal system to the sinusoidal (sec-
onday) capillary plexus within the adenohypophysis,
where a portion of the GnRH leaves the capillaries and
thereby becomes available for binding to its pituitary tar-
get cells, the gonadotropes. The short distance (and time)
that the GnRH travels in these vessels is where (when) it is
vulnerable to be attacked by antibodies. If enough specific
antibodies are present in the circulating blood entering
the median eminence, then virtually all the GnRH
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body. Binding to antibody "neutralizes" the GnRH either
by preventing it from diffusing through the capillary walls
(due to the complex) or by masking the receptor binding
site on the GnRH molecule itself.
GnRH is too small to be immunogenic. Therefore, the
GnRH molecule must be conjugated to a carrier protein
along with the use of an adjuvant. GnRH vaccination
involves the injection of GnRH (or a modified form of the
hormone, an analogue) conjugated to a foreign protein,
and combined with an adjuvant, to induce anti-GnRH
antibody formation.
Two major factors to be considered in the development of
vaccines against GnRH for commercial use in farm animal
species are the adjuvant used, and the number of immu-
nizations needed for effective immunocastration.
Vaccination of young boars with a GnRH vaccine 
(Improvac®)
Improvac contains a modified form of GnRH (200 ug
GnRH-protein conjugate/ml) in an aqueous adjuvant sys-
tem. The analogue of GnRH, used in this vaccine has no
hormonal effect or chemical activity [9]. The results from
three vaccination studies are briefly presented here: I,
Dunshea et al. [9] (Australia); II, Jaros et al. [10] (Switzer-
land); III, Cronin et al. [11] (Australia). In these studies
the male pigs were vaccinated twice. The second dose,
which is expected to elicit an immune reaction with high
antibody titres against GnRH should be given no later
than 4 to 5 weeks prior to slaughter, to allow any boar
taint substances already present to be metabolised/elimi-
nated.
Experimental protocol
I: Three hundred male (200 boars and 100 barrows) pigs
were used in a 2 × 3 factorially arranged experiment at a
commercial pig enterprise. The respective factors were sex
group (castrated between 1 and 2 weeks of age; vaccinated
with Improvac; placebo vaccinated) and slaughter age (23
or 26 weeks). They were allocated within sex to pens of 10
according to treatment. Pigs to be slaughtered at 23 weeks
of age were vaccinated at 15 and 19 weeks of age, whereas
pigs slaughtered at 26 weeks of age were vaccinated at 18
and 22 weeks of age. Boars were vaccinated under a dou-
ble-blind study protocol.
The injection sites of each pig were inspected by palpation
at weekly intervals for 4 weeks. At slaughter "fighting
lesions" around the neck and shoulders were recorded.
II: A total of 533 male pigs from two different breeding
farms were used. After parturition, male piglets of each lit-
ter were randomly assigned to two groups, with 270 ani-
mals for immunocastration and 263 animals for surgical
castration (controls) within the first 14 days of life. After
weaning at 25 kg of weight, all littermates (intact males
and barrows) were transported to two different farms. In
the new farms pigs were kept in pen-groups of 10 animals,
independent of their sex. Pigs were vaccinated twice at an
interval of at least 4 to 5 weeks with the second dose being
given 4 to 6 weeks prior to slaughter. The animals were
slaughtered at 100–110 kg bodyweight.
III: The behaviour of group-housed, male finisher pigs
was studied. Twelve groups of 15 male pigs were formed
at 14 weeks of age (47 kg mean live weight). Pig behaviour
was compared among groups of entire males, immuno-
castrated males (treated with Improvac at 14 and 18 weeks
of age) and surgically castrated males (castrated at 14 days
old). A 24-hour time-lapse video record was made for
each pen of pigs at 17 and 21 weeks of age.
Results
Antibody response and testes
In pigs treated with two doses of Improvac, an immune
response against GnRH was detectable in all animals (I).
The response was lower in some pigs but never below a
titer of 100. The primary dose of the GnRH vaccine
seemed to have had no physiological effect on testicular
function as assessed by the testicular size and serum testo-
sterone concentrations at the time of the secondary dose.
However, within 2 weeks of the second vaccination, testic-
ular growth and secretion of testosterone were sup-
pressed. At slaughter, testes weight and bulbo-urethral
gland weight were approximately 50% lighter in the vac-
cinated pigs (I, II).
Androstenone and skatole in subcutaneous fat (I, II)
Placebo-treated boars had fat androstenone levels almost
eight times greater than those of the Improvac-treated
boars, which were not different from the barrows. Pla-
cebo-vaccinated boars had fat skatole levels almost twice
as high as those of the Improvac-treated boars, which were
not different from the barrows.
Site reactions and carcass lesions (I)
The majority of vaccinated boars showed no reaction fol-
lowing subcutaneous treatment (no difference between
Improvac or placebo vaccination). Many of the pigs that
exhibited site reactions did so at only one time point. At
slaughter there were no visible site reactions in any pigs,
whereas in 12 out of 192 vaccinated pigs there was a reac-
tion that could be detected by palpation. "Fighting
lesions" around the head and shoulders were recorded in
30 pigs, 26 of which belonged to the placebo group and 6
were Improvac-treated boars. They probably arose due to
fighting during transport to the abattoir and/or in thePage 2 of 4
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fighting scars were found among the barrows.
Efficiency of lean meat production
There were indications that the per cent of lean meat was
higher in Improvac vaccinated than in surgically castrated
animals.
Behaviour (III)
The Improvac vaccinated pigs spent less time engaged in
socio-sexual behaviour than intact male pigs after the sec-
ondary vaccination (recorded at 21 weeks of age); at this
age there was no difference in socio-sexual or feeding
behaviour between the Improvac vaccinated and the sur-
gically castrated male pigs.
Advantages and disadvantages with Improvac 
vaccination
Advantages
• Avoid surgical procedure of male piglets, which is asso-
ciated with some pain and stress even when performed
under local or general anaesthesia.
• Two vaccinations with 4 to 6 weeks interval, the last
administered approximately 4 weeks before slaughter is
effective in reducing the androstenone and skatole con-
centrations in fat to levels similar to those observed in pigs
surgically castrated before 2 weeks of age. Only 3 per cent
of the Improvac-treated boars and none of the barrows
had fat androstenone concentrations of 0.5 – 1.0 μg/g fat
[9]. The European Union accept a threshold level of 0.5 μg
androstenone/g fat. In another study [10] only 2 out of
270 immunocastrated animals had androstenone concen-
trations above 0.5 μg/g fat (1.0 and 1.4 μg/g fat respec-
tively). Those 2 animals had also high testicular weights
(> 500 g). The reason for this is not clear, but may most
likely be due to lack of immunological response; the anti-
body titer varies between individuals. Corresponding
results were obtained for skatole concentrations. The few
GnRH vaccinated pigs that had intermediate concentra-
tions of either androstenone or skatole at slaughter did
not have significant levels of both compounds.
• The aqueous proprietary adjuvant system of Improvac
caused very little irritation at the injection site of the vac-
cinated pigs.
• A decrease in aggressive and sexual behaviour was
observed after the secondary Improvac vaccination, as a
consequence of suppression of testicular function. The
decrease in "fighting lesions" exhibited after transport and
lairage in the vaccinated boars is also ascribed to the
reduced aggressive behaviour in these animals.
• The male pig is left intact for most of its production life,
thus gaining the natural growth advantages of boars.
Disadvantages
• For effective immunization against androstenone
(development of anti-GnRH antibodies) two vaccinations
4 weeks apart are required, the seconday given 4 to 5
weeks prior to slaughter. It is not very easy to vaccinate
group-penned pigs of that weight.
• To avoid accidental self injection by operators, this
product should be administered using a vaccinator which
employs a needle safety shield. According to the recom-
mendations given by the vaccine producer, "the operators
should be trained in procedures for safe use of this mate-
rial. Not to be used by women of child bearing age".
• Due to individual variation in immunological response
to Improvac, a few vaccinated male pigs will still have too
high concentrations of andostenone in the fat. On the
other hand, it also occurs that cryptorchids are sent to
slaughter as barrows. Cryptorchids have taint of the same
magnitude as entire males.
Recommendations
Further clinical tests under careful supervision are needed
before considering the introduction of this method in
Scandinavian countries. Special attention should be paid
to the communication with consumers. It is very impor-
tant with correct information regarding both advantages
and disadvantages of Improvac to consumers and farmers.
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